Market Exclusive

Meridian Bioscience (NASDAQ:VIVO) reported earnings of $0.21 per share meeting Walls Streets expectations.

Meridian Bioscience (NASDAQ:VIVO) reported Q2 2018 earnings this Morning, coming in at $0.21 per share, in-line Wall Street’s estimates of $0.21 per Share. Revenue for the quarter came in at $56.45 million beating analyst estimates of $55.00 million Recent Insider Trading for Meridian Bioscience (NASDAQ:VIVO)

Dividend History for Meridian Bioscience (NASDAQ:VIVO)

Recent Trading for Meridian Bioscience (NASDAQ:VIVO) Shares of Meridian Bioscience closed the previous trading session at 14.36 up +0.01 0.04% with 14.399999618530273 shares trading hands.

Exit mobile version